相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。SGLT2 inhibition restrains thyroid cancer growth via G1/S phase transition arrest and apoptosis mediated by DNA damage response signaling pathways
Yan Wang et al.
CANCER CELL INTERNATIONAL (2022)
SPARC, a Novel Regulator of Vascular Cell Function in Pulmonary Hypertension
Christine Veith et al.
CIRCULATION (2022)
Diagnosis and Treatment of Pulmonary Arterial Hypertension A Review
Nicole F. Ruopp et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2022)
The SGLT2 inhibitor canagliflozin in heart failure: the CHIEF-HF remote, patient-centered randomized trial
John A. Spertus et al.
NATURE MEDICINE (2022)
Dapagliflozin, sildenafil and their combination in monocrotaline-induced pulmonary arterial hypertension
Yi Tang et al.
BMC PULMONARY MEDICINE (2022)
Empagliflozin prevents neointima formation by impairing smooth muscle cell proliferation and accelerating endothelial regeneration
Jochen Dutzmann et al.
FRONTIERS IN CARDIOVASCULAR MEDICINE (2022)
Dapagliflozin reduces the vulnerability of rats with pulmonary arterial hypertension-induced right heart failure to ventricular arrhythmia by restoring calcium handling
Jinchun Wu et al.
CARDIOVASCULAR DIABETOLOGY (2022)
The SGLT2 inhibitor Empagliflozin attenuates interleukin-17A-induced human aortic smooth muscle cell proliferation and migration by targeting TRAF3IP2/ROS/NLRP3/Caspase-1-dependent IL-1β and IL-18 secretion
Sergiy Sukhanov et al.
CELLULAR SIGNALLING (2021)
Effects of Sodium-Glucose Co-Transporter 2 Inhibitors on Vascular Cell Function and Arterial Remodeling
William Durante et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Molecular genetic framework underlying pulmonary arterial hypertension
Laura Southgate et al.
NATURE REVIEWS CARDIOLOGY (2020)
The SGLT2 inhibitor empagliflozin reduces mortality and prevents progression in experimental pulmonary hypertension
Biswajit Chowdhury et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2020)
Role of the GLUT1 Glucose Transporter in Postnatal CNS Angiogenesis and Blood-Brain Barrier Integrity
Koen Veys et al.
CIRCULATION RESEARCH (2020)
Canagliflozin inhibits vascular smooth muscle cell proliferation and migration: Role of heme oxygenase-1
Ghazaleh Behnammanesh et al.
REDOX BIOLOGY (2020)
AMPKα2 deficiency exacerbates hypoxia-induced pulmonary hypertension by promoting pulmonary arterial smooth muscle cell proliferation
Hai-Long Wang et al.
JOURNAL OF PHYSIOLOGY AND BIOCHEMISTRY (2020)
Magnesium lithospermate B ameliorates hypobaric hypoxia-induced pulmonary arterial hypertension by inhibiting endothelial-to-mesenchymal transition and its potential targets
Yafeng Wang et al.
BIOMEDICINE & PHARMACOTHERAPY (2020)
ADAMTS8 Promotes the Development of Pulmonary Arterial Hypertension and Right Ventricular Failure A Possible Novel Therapeutic Target
Junichi Omura et al.
CIRCULATION RESEARCH (2019)
Clinical trial design and new therapies for pulmonary arterial hypertension
Olivier Sitbon et al.
EUROPEAN RESPIRATORY JOURNAL (2019)
Pulmonary arterial hypertension: pathogenesis and clinical management
Thenappan Thenappan et al.
BMJ-BRITISH MEDICAL JOURNAL (2018)
Pulmonary arterial hypertension: pathogenesis and clinical management
Thenappan Thenappan et al.
BMJ-BRITISH MEDICAL JOURNAL (2018)
Alpha-enolase regulates the malignant phenotype of pulmonary artery smooth muscle cells via the AMPK-Akt pathway
Jingbo Dai et al.
NATURE COMMUNICATIONS (2018)
Fructose-1,6-bisphosphate and aldolase mediate glucose sensing by AMPK
Chen-Song Zhang et al.
NATURE (2017)
Sodium Glucose Cotransporter-2 Inhibition in Heart Failure Potential Mechanisms, Clinical Applications, and Summary of Clinical Trials
Yuliya Lytvyn et al.
CIRCULATION (2017)
Activation of AMPK inhibits PDGF-induced pulmonary arterial smooth muscle cells proliferation and its potential mechanisms
Yang Song et al.
PHARMACOLOGICAL RESEARCH (2016)
Pro-proliferative and inflammatory signaling converge on FoxO1 transcription factor in pulmonary hypertension
Rajkumar Savai et al.
NATURE MEDICINE (2014)
Shroom expression is attenuated in pulmonary arterial hypertension
J. Sevilla-Perez et al.
EUROPEAN RESPIRATORY JOURNAL (2008)